Evidence map›Paper›PMID 17881516›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2007

System x(c)- activity and astrocytes are necessary for interleukin-1 beta-mediated hypoxic neuronal injury.

Birgit Fogal, Jun Li, Doug Lobner, Louise D McCullough, Sandra J Hewett

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 68 papers.

0numbers the graph read from it
0cells of the map it votes in
68citing papers in PubMed
4.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

68 citing papers in PubMed, 111 citations in OpenAlex.

  1. Plasma Cystine as a Marker of Acute Stroke Severity.Diagnostics (Basel, Switzerland) · 2025
    Article
  2. Article
  3. Sulfide regulation and catabolism in health and disease.Signal transduction and targeted therapy · 2025
    Review
  4. Article
  5. Article
  6. Review
  7. Autism Spectrum Disorder: Focus on Glutamatergic Neurotransmission.International journal of molecular sciences · 2022
    Review
  8. Article
  9. Review
  10. The Cystine/Glutamate Antiporter, System xFrontiers in cellular neuroscience · 2022
    Article
  11. Article
  12. Influence of glutamate and GABA transport on brain excitatory/inhibitory balance.Experimental biology and medicine (Maywood, N.J.) · 2021
    Review
  13. Article
  14. Validation of a System xFrontiers in cellular neuroscience · 2021
    Article
  15. Review
  16. Article
  17. Review
  18. Nrf2-Mediated System xMolecular neurobiology · 2019
    Article
  19. Article
  20. Review

8 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Birgit FogalDepartment of Neuroscience, University of Connecticut Health Center, Farmington, Connecticut 06030, USA.
Jun Li
Doug Lobner
Louise D McCullough
Sandra J Hewett
UConn Health · USMarquette University · US

Funding

Excitotoxicity and InflammationR01NS036812 · NINDS · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI HEWETT, SANDRA J · 2002 to 2013
$3.5M
IL-1 in Protection and InjuryR01NS051445 · NINDS · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI HEWETT, SANDRA J · 2006 to 2017
$3.2M
IL-1 mediated potentiation of hypoxic neuronal injuryF31NS052061 · NINDS · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI FOGAL, BIRGIT · 2005 to 2007
$57k
NINDS NIH HHS F31 NS052061NINDS NIH HHS NS51445NINDS NIH HHS NS52061NINDS NIH HHS R01 NS036812NINDS NIH HHS R01 NS051445
6 · The paper itself

Abstract

The purpose of this study was to elucidate the cellular/biochemical pathway(s) by which interleukin-1beta (IL-1beta) contributes to the pathogenesis of hypoxic-ischemic brain damage. In vivo, IL-1 receptor type I (IL-1RI)-deficient mice showed smaller infarcts and less neurological deficits than wild-type animals after a 90 min reversible middle cerebral artery occlusion. In vitro, IL-1beta mediated an enhancement of hypoxic neuronal injury in murine cortical cultures that was lacking in cultures derived from IL-1RI null mutant animals and was blocked by the IL-1 receptor antagonist or an IL-1RI blocking antibody. This IL-1beta-mediated potentiation of hypoxic neuronal injury was associated with an increase in both cellular cystine uptake ([cystine]i) and extracellular glutamate levels ([glutamate]e) and was prevented by either ionotropic glutamate receptor antagonism or removal of L-cystine, suggesting a role for the cystine/glutamate antiporter (System x(c)-). Indeed, dual System x(c)-/metabotropic glutamate receptor subunit 1 (mGluR1) antagonism but not selective mGluR1 antagonism prevented neuronal injury. Additionally, cultures derived from mGluR1-deficient mice exhibited the same potentiation in injury after treatment with IL-1beta as wild-type cultures, an effect prevented by System x(c)-/mGluR1 antagonism. Finally, assessment of System x(c)- function and kinetics in IL-1beta-treated cultures revealed an increase in velocity of cystine transport (Vmax), in the absence of a change in affinity (Km). Neither the enhancement in [cystine]i, [glutamate]e, or neuronal injury were observed in chimeric cultures consisting of IL-1RI(+/+) neurons plated on top of IL-1RI(-/-) astrocytes, highlighting the importance of astrocyte-mediated alterations in System x(c)- as a novel contributor to the development and progression of hypoxic neuronal injury.

Indexed as

Amino Acid Transport System y+AnimalsAstrocytesCell DeathCells, CulturedCoculture TechniquesHypoxia-Ischemia, BrainInterleukin-1betaMaleMiceMice, Inbred C57BLMice, KnockoutNeuronsAmino Acid Transport System y+Interleukin-1betaSlc7a11 protein, mouse

Identifiers

PMID17881516
PMCPMC6672668
OpenAlexW2062639408

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.